Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Free Report) have received an average rating of “Hold” from the five ...

C4 Therapeutics (NASDAQ:CCCC) stock is heading higher on Tuesday as investors in the clinical-stage biopharmaceutical company celebrate a new license and research collaboration with Merck (NYSE ...

Financially stable C4 Therapeutics (CCCC) is worth watching for patient investors, but current lack of definitive data poses ...

Capital One Financial To Acquire Discover, Joins SSR Mining And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session U.S. stock futures were lower this morning, with the Dow futures ...

And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on CCCC going forward to see if this recent jump can ...

The latest update is out from C4 Therapeutics ( (CCCC) ).

View C4 Therapeutics, Inc. (CCCC) current and estimated P/E ratio data provided by Seeking Alpha.

C4 Therapeutics (CCCC) announced the continued evolution of its Board of Directors with the appointment of Steve Hoerter as a director. Don't ...

China Shineway Pharmaceutical Group Ltd.-16.08% +0.00% China Shineway Pharmaceutical Group Ltd. +0.00% +0.00% ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.